Cabot Corporation
CBT
Jodie read · what matters now
Revenue decreased 3.4% versus the comparable filing period.
The story is only the start. Jodie keeps watching the filing evidence, the companies connected to CBT, and whether its market group begins moving.
Latest filing assessment · baseline
The latest filing shows material pressure
10-Q filed 2026-05-06 against the comparable filing from 2025-05-07.
What improved
No thresholded improvement was identified.
What weakened
- Revenue decreased 3.4% versus the comparable filing period.
- Operating margin fell 3.0 percentage points.
- Net income decreased 27.7% versus the comparable filing period.
Filing receipts
“The lower volumes were primarily due to lower volumes in our fumed metal oxides product line from lower demand and the less favorable pricing and product mix was primarily due to lower raw material costs which, in certain instances, are passed through to our customers through formulas and other market-based adjustments.”
“The decrease in Net sales and other operating revenue in the first six months of fiscal 2026 compared to the same period of fiscal 2025 was primarily driven by less favorable pricing and product mix ($162 million combined), primarily in our Reinforcement Materials segment, and lower volumes ($30 million combined), primarily in our Reinforcement Material segment, partially offset by the favorable impact from foreign currency translation in both our Reinforcement Materials and Performance Chemicals segments ($58 million combined).”
“Second quarter of Fiscal 2026 versus Second quarter of Fiscal 2025—By Business Segment Reinforcement Materials Sales and EBIT for Reinforcement Materials for the second quarter of fiscal 2026 and 2025 were as follows: Three Months Ended March 31 Six Months Ended March 31 2026 2025 2026 2025 (In millions) Reinforcement Materials Sales $ 544 $ 594 $ 1,064 $ 1,205 Reinforcement Materials EBIT $ 93 $ 131 $ 195 $ 261 Sales in Reinforcement Materials decreased by $50 million in the second quarter of fiscal 2026 compared to the same period of fiscal 2025 primarily due to less favorable pricing and product mix ($95 million), partially offset by higher volumes ($21 million) and the favorable impact...”
Retrospective baseline calibration. It was generated after the filing date and is not part of Jodie's live track record.
Who this business touches
The relationships behind CBT
Customers, suppliers, partners and competitors named in company filings—not inferred from headlines.
Depends on
Depended on by
Filing peers
Companies whose filings use similar operating language.
You can see the shape of the network here. Pro opens 1 more links, the original filing receipts, and alerts when connected names begin moving. See Pro →
What is moving around it
Live connections
CBT is currently a Leader in the organic co-movement group Specialty Chemicals. This group is discovered from market behaviour rather than assigned from an industry taxonomy. 2 filing-linked names are in the relationship map; none is currently confirmed as moving with the group.
This group is retained as the last observed read for CBT; it is not active in the latest market snapshot.
Theme membership history
No durable theme membership has been observed for this name yet.